Cash & equivalents increased 55.7%
Cash & equivalents changed +55.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +55.7% from the comparable as-filed period.
Gross profit changed +21.0% from the comparable as-filed period.
Net income changed +498.9% from the comparable as-filed period.
Operating income changed +121.4% from the comparable as-filed period.
Operating margin changed +377 basis points from the comparable as-filed period.
Revenue changed +22.5% from the comparable as-filed period.
Selling, general & administrative changed +15.7% from the comparable as-filed period.
Gross margin changed -89 basis points from the comparable as-filed period.
Inventory changed +9.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +11.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.